X4 Pharmaceuticals, Inc. (XFOR)
3.82
+0.18
(+4.95%)
USD |
NASDAQ |
Dec 10, 12:25
X4 Pharmaceuticals Research and Development Expense (TTM): 75.34M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc. | 10.13B |
| Altimmune, Inc. | 67.72M |
| Adverum Biotechnologies, Inc. | 128.88M |
| Recursion Pharmaceuticals, Inc. | 433.37M |
| Quantum-Si, Inc. | 58.38M |